{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06015737",
            "orgStudyIdInfo": {
                "id": "D346BC00001"
            },
            "secondaryIdInfos": [
                {
                    "id": "2021-003698-70",
                    "type": "EUDRACT_NUMBER"
                }
            ],
            "organization": {
                "fullName": "AstraZeneca",
                "class": "INDUSTRY"
            },
            "briefTitle": "A 2-stage, Phase III Study on the Effectiveness and Safety of Anifrolumab in Adults With Chronic and/or Subacute Cutaneous Lupus Erythematosus",
            "officialTitle": "A Multicenter, Randomized, Double Blind, Placebo Controlled, Phase III Study to Evaluate the Effectiveness and Safety of Anifrolumab in Adults With Chronic and/or Subacute Cutaneous Lupus Erythematosus Who Are Refractory and/or Intolerant to Antimalarial Therapy",
            "acronym": "LAVENDER",
            "therapeuticArea": [
                "Immunology and Rheumatology"
            ],
            "study": "a-stage-phase-iii-study-on-the-effectiveness-and-safety-of-anifrolumab-in-adults-with-chronic-and-or-subacute-cutaneous-lupus-erythematosus"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-05",
            "overallStatus": "NOT_YET_RECRUITING",
            "startDateStruct": {
                "date": "2024-06-17",
                "type": "ESTIMATED"
            },
            "primaryCompletionDateStruct": {
                "date": "2028-01-27",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2028-01-27",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-08-01",
            "studyFirstSubmitQcDate": "2023-08-22",
            "studyFirstPostDateStruct": {
                "date": "2023-08-29",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-05-15",
            "lastUpdatePostDateStruct": {
                "date": "2024-05-16",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "AstraZeneca",
                "class": "INDUSTRY"
            },
            "collaborators": [
                {
                    "name": "Parexel",
                    "class": "INDUSTRY"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This study aims to assess the efficacy and safety of subcutaneous (SC) anifrolumab versus placebo in adult patients with cutaneous lupus erythematosus (CLE).",
            "detailedDescription": "The primary objectives of the study are to assess the efficacy of anifrolumab compared with placebo in reducing skin disease in patients with active chronic and/or subacute CLE who are refractory and/or intolerant to antimalarial therapy. The secondary objectives of the study are to assess additional efficacy parameters of anifrolumab, safety, tolerability, quality of life, pharmacokinetics, pharmacodynamics, and immunogenicity. Stage 1 and Stage 2 of the study will have broadly identical study designs with the exception of sample size. Both Stages of the study will have a randomized, double-blind, placebo-controlled design, followed by an open-label treatment period."
        },
        "conditionsModule": {
            "conditions": [
                "Cutaneous Lupus Erythematosus"
            ],
            "keywords": [
                "Lupus erythematosus",
                "Cutaneous lupus erythematosus",
                "Anifrolumab",
                "Cutaneous Lupus Erythematosus Disease Area Severity Index",
                "Cutaneous lupus activity - Investigator's Global Assessment - Revised"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE3"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "interventionModelDescription": "This is a parallel group treatment study in two concurrent stages (Stage 1 and Stage 2) and each stage will have two arms.",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "DOUBLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "INVESTIGATOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 460,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Stage 1: Anifrolumab",
                    "type": "EXPERIMENTAL",
                    "description": "The participants will receive anifrolumab as a SC injection from Week 0/Day 1 up to and including week 51.",
                    "interventionNames": [
                        "Combination Product: Anifrolumab"
                    ]
                },
                {
                    "label": "Stage 1: Placebo",
                    "type": "PLACEBO_COMPARATOR",
                    "description": "The participant will receive placebo as a SC injection from Week 0/Day 1 to Week 23. From Week 24 the participants will receive anifrolumab up to and including Week 51.",
                    "interventionNames": [
                        "Other: Placebo"
                    ]
                },
                {
                    "label": "Stage 2: Anifrolumab",
                    "type": "EXPERIMENTAL",
                    "description": "The participants will receive anifrolumab as a SC injection from Week 0/Day 1 up to and including week 51.",
                    "interventionNames": [
                        "Combination Product: Anifrolumab"
                    ]
                },
                {
                    "label": "Stage 2: Placebo",
                    "type": "PLACEBO_COMPARATOR",
                    "description": "The participant will receive placebo as a SC injection from Week 0/Day 1 to Week 23. From Week 24 the participants will receive anifrolumab up to and including Week 51.",
                    "interventionNames": [
                        "Other: Placebo"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "COMBINATION_PRODUCT",
                    "name": "Anifrolumab",
                    "description": "Anifrolumab will be provided as a solution for injection in accessorized pre-filled syringe (aPFS).",
                    "armGroupLabels": [
                        "Stage 1: Anifrolumab"
                    ]
                },
                {
                    "type": "OTHER",
                    "name": "Placebo",
                    "description": "Matching placebo solution for injection in aPFS.",
                    "armGroupLabels": [
                        "Stage 1: Placebo"
                    ]
                },
                {
                    "type": "COMBINATION_PRODUCT",
                    "name": "Anifrolumab",
                    "description": "Anifrolumab will be provided as a solution for injection in accessorized pre-filled syringe (aPFS).",
                    "armGroupLabels": [
                        "Stage 2: Anifrolumab"
                    ]
                },
                {
                    "type": "OTHER",
                    "name": "Placebo",
                    "description": "Matching placebo solution for injection in aPFS.",
                    "armGroupLabels": [
                        "Stage 2: Placebo"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Stage 1 and Stage 2 (United States [US]): Number of participants with Cutaneous Lupus Activity of Investigator's Global Assessment-Revised (CLA-IGA-R) erythema score of 0 or 1 and at least a 2- point reduction relative to baseline",
                    "description": "The CLA-IGA-R is an assessment tool that scores the three key disease components (erythema; other morphological characteristics \\[OMC\\] and follicular activity) of CLE independently. The CLA-IGA-R erythema is scored on a five-point binary scale that provides a global clinical assessment ranging from 0 to 4 (0 indicates clear, 1 is almost clear, 2 is mild, 3 is moderate, and 4 indicates severe CLE). On all IGA scales, a decrease in score relates to an improvement in signs and symptoms. CLA-IGA-R erythema responder is defined as a participant who achieves a CLA-IGA-R erythema score of 0 or 1 and at least a 2-point reduction relative to baseline. Otherwise, the participant is considered a non-responder.",
                    "timeFrame": "At Week 24"
                },
                {
                    "measure": "Stage 1 and Stage 2 (European Union [EU]/Rest of the World [ROW]: Number of participants with a 70% reduction relative to baseline in the Cutaneous Lupus Erythematosus Disease Area and Severity Index-Activity (CLASI-A) score",
                    "description": "CLASI is a validated index used for assessing the cutaneous lesions of SLE. The CLASI instrument will be used at each study visit to capture individual skin manifestation scores. CLASI-70 responder (Yes/No) is defined as a participant who achieves a 70% reduction relative to baseline in CLASI-A score. Otherwise, the participant is considered a non-responder.",
                    "timeFrame": "At Week 24"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Stage 1 and Stage 2 (US): Number of participants who achieve a CLA-IGA-R OMC score of 0 or 1 and at least a 1-point reduction relative to baseline",
                    "description": "The CLA-IGA-R is an assessment tool that scores the three key disease components (erythema; OMC and follicular activity) of CLE independently. The CLA-IGA-R OMC is scored on a five-point binary scale that provides a global clinical assessment ranging from 0 to 4, where 0 indicates clear, 1 is almost clear, 2 is mild, 3 is moderate, and 4 indicates severe CLE. Assessment of CLA-IGA-R OMC score captures other morphological changes in CLE patients. A decrease in score relates to an improvement in signs and symptoms. A responder (yes/no) is defined as a participant who achieves a CLA-IGA-R OMC score of 0 or 1 and at least a 1-point reduction relative to baseline. Otherwise, the participant is considered a non-responder.",
                    "timeFrame": "At Week 24"
                },
                {
                    "measure": "Stage 1 and Stage 2 (US): Number of participants who achieve a CLA-IGA-R OMC score of 0.",
                    "description": "The CLA-IGA-R is an assessment tool that scores the three key disease components (erythema; OMC and follicular activity) of CLE independently. The CLA-IGA-R OMC is scored on a five-point binary scale that provides a global clinical assessment ranging from 0 to 4, where 0 indicates clear, 1 is almost clear, 2 is mild, 3 is moderate, and 4 indicates severe CLE. CLA-IGA-R OMC complete response is defined as a participant who scores 0. Otherwise, the participant is a non-responder. Only participants with CLA-IGA-OMC \u2265 3 at baseline will be included in the analysis.",
                    "timeFrame": "At Week 24"
                },
                {
                    "measure": "Stage 1 and Stage 2 (US): Number of participants with CLA-IGA-R follicular activity score of 0",
                    "description": "The CLA-IGA-R is a tool that scores the three key disease components (erythema; OMC and follicular activity) of CLE independently.\n\nCLA-IGA-R follicular activity provides a global clinical assessment on a 2-point binary scale ranging from 0 to 1, where 0 indicates absent and 1 indicates present. On all IGA scales, a decrease in score relates to an improvement in signs and symptoms. A responder (yes/no) is defined as a participant who achieves a CLA-IGA-R follicular activity score of 0. Otherwise, the participant is a non-responder. Only participants with follicular activity score of 1 at baseline will be included in the analysis.",
                    "timeFrame": "At Week 24"
                },
                {
                    "measure": "Stage 1 and Stage 2 (EU/ROW): Percent change from baseline in total CLASI-A erythema score",
                    "description": "The Cutaneous Lupus Erythematosus Disease Area and Severity Index-Activity (CLASI-A) is a validated index used for assessing the cutaneous lesions of SLE. The CLASI-A erythema score is interpreted as follows: 0-absent; 1-pink; faint erythema; 2-red; 3-dark red; purple/violaceous/crusted/ hemorrhagic",
                    "timeFrame": "At Week 24"
                },
                {
                    "measure": "Stage 1 and Stage 2 (EU/ROW): Percent change from baseline in total CLASI-A scale/hypertrophy score",
                    "description": "The CLASI-A is a validated index used for assessing the cutaneous lesions of SLE. CLASI-A Scale/Hypertrophy can be measured as 0, 1, and 2 where 0 is absent, 1 is scale, and 2 is verrucuos and hypertrohic.",
                    "timeFrame": "At Week 24"
                },
                {
                    "measure": "Stage 1 and Stage 2 (US): Number of participants with CLA-IGA-R erythema score of 0 or 1 and at least a 2-point reduction relative to baseline, or a CLA-IGA-R OMC score of 0 or 1 and at least a 1-point reduction relative to baseline",
                    "description": "The CLA-IGA-R is a tool that scores the three key disease components (erythema; OMC and follicular activity) of CLE independently. The CLA-IGA-R erythema and OMC are scored on a five-point binary scale that provides a global clinical assessment ranging from 0 to 4, where 0 indicates clear, 1 is almost clear, 2 is mild, 3 is moderate, and 4 indicates severe CLE. A responder (yes/no) is defined as a participant who achieves either a CLA-IGA-R erythema score of 0 or 1 and at least a 2-point reduction relative to baseline, or a CLA-IGA-R OMC score of 0 or 1 and at least a 1-point reduction relative to baseline. Otherwise, the participant is a non-responder. On all IGA scales, a decrease in score relates to an improvement in signs and symptoms.",
                    "timeFrame": "At Week 24"
                },
                {
                    "measure": "Stage 1 and Stage 2 (US): Number of participants with CLA-IGA-R erythema score of 0 or 1 and at least a 2-point reduction relative to baseline",
                    "description": "The CLA-IGA-R is a tool that scores the three key disease components (erythema; OMC and follicular activity) of CLE independently. The CLA-IGA-R erythema is scored on a five-point binary scale that provides a global clinical assessment ranging from 0 to 4 (0 indicates clear, 1 is almost clear, 2 is mild, 3 is moderate, and 4 indicates severe CLE). A responder is defined as a participant who achieves a CLA-IGA-R erythema score of 0 or 1 and at least a 2-point reduction relative to baseline. Otherwise, the participant is a non-responder. On all IGA scales, a decrease in score relates to an improvement in signs and symptoms.",
                    "timeFrame": "At Week 12"
                },
                {
                    "measure": "Stage 1 and Stage 2 (US): Number of participants with CLA-IGA-R OMC score of 0 or 1 and at least a 1-point reduction relative to baseline",
                    "description": "The CLA-IGA-R is a tool that scores the three key disease components (erythema; OMC, and follicular activity) of CLE independently. The CLA-IGA-R OMC is scored on a five-point binary scale that provides a global clinical assessment ranging from 0 to 4 (0 indicates clear, 1 is almost clear, 2 is mild, 3 is moderate, and 4 indicates severe CLE). A responder (yes/no) is defined as a participant who achieves a CLA- IGA-R OMC score of 0 or 1 and at least a 1-point reduction relative to baseline. Otherwise, the participant is a non-responder. On all IGA scales, a decrease in score relates to an improvement in signs and symptoms.",
                    "timeFrame": "At Week 12"
                },
                {
                    "measure": "Stage 1 and Stage 2 (EU/ROW): Number of participants with CLASI-70 response",
                    "description": "The CLASI is a validated index used for assessing the cutaneous lesions of SLE. CLASI-70 responder is defined as a participant who achieves a 70% reduction relative to baseline in CLASI-A score. Otherwise, the participant is considered a non-responder.",
                    "timeFrame": "At Week 12"
                },
                {
                    "measure": "Stage 1 and Stage 2 (US/EU/ROW): Change from baseline in Skindex-29+3 domain scores",
                    "description": "The Skindex-29+3 is based on a previous instrument, the Skindex-29 and has been modified to include items related to CLE. The instrument consists of 33 items, which are used to calculate 4 domains: Symptoms (7 items), Emotions (10 items), Functioning (12 items), and Lupus-specific (3 items). The remaining item asks the participants to rate how often they worry about side effects from treatment; however, this item is not used to calculate the domain scores. The response options are on a 5-point verbal rating scale, ranging from 1 (Never) to 5 (All the time). The instrument has a recall period of the previous 4 weeks. Each domain score ranges from 0 to 100 points, with higher scores indicating worse health-related quality of life. The symptom domain in the Skindex-29+3 evaluates the symptom burden of the disease and includes symptom concepts such as pain, itching, burning, stinging, and sensitivity.",
                    "timeFrame": "At Week 24"
                },
                {
                    "measure": "Stage 1 and Stage 2 (US/EU/ROW): Serum trough (pre-dose) concentrations of anifrolumab",
                    "description": "The Ctrough of subcutaneously administered anifrolumab in participants with chronic and/or subacute CLE will be evaluated.",
                    "timeFrame": "Double-blind: Pre-dose on Day 1 (Week 0), Weeks 1, 4, 12, 24; Open-label: Weeks 40, and 52 or early discontinuation visit [EDV] and follow-up visit (13 Weeks after last dose)"
                },
                {
                    "measure": "Stage 1 and Stage 2 (US/EU/ROW): Number of participants with positive antidrug antibody",
                    "description": "The immunogenicity of subcutaneously administered anifrolumab in participants with chronic and/or subacute CLE will be evaluated.",
                    "timeFrame": "Double-blind: Pre-dose on Day 1 (Week 0), Weeks 4, 12, and 24; Open-label: Pre-dose on Weeks 40, and 52 or EDV and follow-up visit (13 weeks after last dose)"
                },
                {
                    "measure": "Stage 1 and Stage 2 (US/EU/ROW): Percent change from baseline in suppression of the Interferon 21-gene",
                    "description": "The pharmacodynamics of subcutaneously administered anifrolumab in participants with chronic and/or subacute CLE will be evaluated.",
                    "timeFrame": "Double-blind: Day 1 (Week 0), Week 1, 4, 12, and 24; Open-label; Week 40 and 52 or EDV and follow-up visit (13 weeks after last dose)"
                },
                {
                    "measure": "Stage 2 (US/EU/ROW): Number of participants with \u2265 7-point reduction from baseline in CLASI-A total score",
                    "description": "The CLASI is a validated index used for assessing the cutaneous lesions of SLE. It consists of 2 separate scores: i) activity of the disease, and ii) measure of damage. The CLASI instrument will be used at each study visit to capture individual skin manifestation scores. A 7-point reduction CLASI-A is established as clinically meaningful improvement in disease for CLE and as being impactful for patients. Achieving a CLASI-A total score of 9 or below is an accepted threshold for mild disease.",
                    "timeFrame": "At Week 24"
                },
                {
                    "measure": "Stage 2 (US): Number of participants who are CLA-IGA-R erythema responders from Week 24 up to and including Week 52",
                    "description": "The CLA-IGA-R is an assessment tool that scores the three key disease components (erythema; OMC and follicular activity) of CLE independently. The CLA-IGA-R erythema is scored on a five-point binary scale that provides a global clinical assessment ranging from 0 to 4, where 0 indicates clear, 1 is almost clear, 2 is mild, 3 is moderate, and 4 indicates severe CLE. On all IGA scales, a decrease in score relates to an improvement in signs and symptoms. Assessment of CLA-IGA-R erythema score captures changes in erythema, a clinically important feature in CLE patients. A responder is defined as a participant who achieves a CLA- IGA-R erythema score of 0 or 1 and at least a 2-point reduction relative to baseline. Otherwise, the participant is a non-responder. Amongst participants randomized to anifrolumab during the double-blind treatment period, the number of participants who maintained a CLA-IGA-R erythema response from Week 24 up to Week 52 will be evaluated.",
                    "timeFrame": "Up to Week 52"
                },
                {
                    "measure": "Stage 2 (EU): Number of participants who are CLASI-70 responders up to and including Week 52",
                    "description": "The CLASI is a validated index used for assessing the cutaneous lesions of SLE. CLASI-70 responder is defined as a participant who achieves a 70% reduction relative to baseline in CLASI-A score. Otherwise, the participant is considered a non-responder. Amongst participants randomized to anifrolumab during the double-blind treatment period, the number of participants who maintained a CLASI-70 response from Week 24 up to Week 52 will be evaluated.",
                    "timeFrame": "Up to Week 52"
                }
            ],
            "otherOutcomes": [
                {
                    "measure": "Stage 1 and Stage 2 (US, EU and ROW): Number of participants with adverse events",
                    "description": "To evaluate the safety and tolerability of anifrolumab compared with placebo in participants with CLE.",
                    "timeFrame": "Screening (up to and including 42 days before Day 1) until Safety Follow-up Period (13 weeks from Week 52/ EDV)"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Key inclusion criteria:\n\n* Participants must have a confirmed diagnosis of CLE. Diagnosis must be clinically and histologically confirmed with the following:\n\n  * CLASI-A total score \u2265 10 points at Screening and confirmed at randomization.\n  * CLA-IGA-R erythema score of \u2265 3 and CLA-IGA-R-OMC score of \u2265 1 at Screening and confirmed at randomization.\n  * Inadequate response or intolerant to antimalarial therapy.\n* Participants should have no medical history or signs or symptoms of active or prior tuberculosis infection (TB) and the same should reflect in chest radiograph or a chest CT scan result.\n* Contraceptive use by males and females should be consistent with local regulations regarding the methods of contraception for those participating in clinical studies.\n* Participants should have a coronavirus disease 2019 (COVID-19) negative PCR or antigen test result as per local policies at Screening.\n\nKey exclusion criteria:\n\n* History or evidence of suicidal ideation.\n* Severe or life-threatening Systemic lupus erythematosus (SLE).\n* Active SLE or Sj\u00f6gren's Syndrome.\n* Any active skin conditions other than CLE that may interfere with the study.\n* History of recurrent infection requiring hospitalization and IV antibiotics.\n* COVID-19 infection\n* Any history of an anaphylactic reaction to human proteins, or monoclonal antibodies.\n* At screening, if participants do not meet the eligibility criteria assessed based on laboratory test results e.g tests for total bilirubin, serum creatinine etc.\n\nNOTE: Other protocol defined Inclusion/Exclusion criteria may apply",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "maximumAge": "70 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "AstraZeneca Clinical Study Information Center",
                    "role": "CONTACT",
                    "phone": "1-877-240-9479",
                    "email": "information.center@astrazeneca.com"
                }
            ],
            "locations": [
                {
                    "facility": "Research Site",
                    "city": "Glendale",
                    "state": "Arizona",
                    "zip": "85306",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 33.53865,
                        "lon": -112.18599
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Phoenix",
                    "state": "Arizona",
                    "zip": "85028",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 33.44838,
                        "lon": -112.07404
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "La Jolla",
                    "state": "California",
                    "zip": "92037",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 32.84727,
                        "lon": -117.2742
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Orange",
                    "state": "California",
                    "zip": "92868",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 33.78779,
                        "lon": -117.85311
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "New Haven",
                    "state": "Connecticut",
                    "zip": "06519",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 41.30815,
                        "lon": -72.92816
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Fort Lauderdale",
                    "state": "Florida",
                    "zip": "33309",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 26.12231,
                        "lon": -80.14338
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Miami",
                    "state": "Florida",
                    "zip": "33136",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 25.77427,
                        "lon": -80.19366
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Miami",
                    "state": "Florida",
                    "zip": "33174",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 25.77427,
                        "lon": -80.19366
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Plantation",
                    "state": "Florida",
                    "zip": "33324",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 26.13421,
                        "lon": -80.23184
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Boston",
                    "state": "Massachusetts",
                    "zip": "02115-5817",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 42.35843,
                        "lon": -71.05977
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Ann Arbor",
                    "state": "Michigan",
                    "zip": "48109",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 42.27756,
                        "lon": -83.74088
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Brooklyn",
                    "state": "New York",
                    "zip": "11201",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 40.6501,
                        "lon": -73.94958
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Rochester",
                    "state": "New York",
                    "zip": "14642",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 43.15478,
                        "lon": -77.61556
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Cleveland",
                    "state": "Ohio",
                    "zip": "44195",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 41.4995,
                        "lon": -81.69541
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Portland",
                    "state": "Oregon",
                    "zip": "97239",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 45.52345,
                        "lon": -122.67621
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Charlottesville",
                    "state": "Virginia",
                    "zip": "22903",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 38.02931,
                        "lon": -78.47668
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Ciudad de Buenos Aires",
                    "zip": "1221",
                    "country": "Argentina",
                    "geoPoint": {
                        "lat": -34.61315,
                        "lon": -58.37723
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "C\u00f3rdoba",
                    "zip": "5000",
                    "country": "Argentina",
                    "geoPoint": {
                        "lat": -31.4135,
                        "lon": -64.18105
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Quilmes",
                    "zip": "1878",
                    "country": "Argentina",
                    "geoPoint": {
                        "lat": -34.72904,
                        "lon": -58.26374
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Box Hill",
                    "zip": "3128",
                    "country": "Australia",
                    "geoPoint": {
                        "lat": -37.81887,
                        "lon": 145.12545
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Clayton",
                    "zip": "3168",
                    "country": "Australia",
                    "geoPoint": {
                        "lat": -37.91667,
                        "lon": 145.11667
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Melbourne",
                    "zip": "3004",
                    "country": "Australia",
                    "geoPoint": {
                        "lat": -37.814,
                        "lon": 144.96332
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Westmead",
                    "zip": "2145",
                    "country": "Australia",
                    "geoPoint": {
                        "lat": -33.80383,
                        "lon": 150.98768
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Woolloongabba",
                    "zip": "04102",
                    "country": "Australia",
                    "geoPoint": {
                        "lat": -27.48855,
                        "lon": 153.03655
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Graz",
                    "zip": "8036",
                    "country": "Austria",
                    "geoPoint": {
                        "lat": 47.06667,
                        "lon": 15.45
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Innsbruck",
                    "zip": "6020",
                    "country": "Austria",
                    "geoPoint": {
                        "lat": 47.26266,
                        "lon": 11.39454
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Linz",
                    "zip": "4020",
                    "country": "Austria",
                    "geoPoint": {
                        "lat": 48.30639,
                        "lon": 14.28611
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Sankt P\u00f6lten",
                    "zip": "3100",
                    "country": "Austria",
                    "geoPoint": {
                        "lat": 48.2,
                        "lon": 15.63333
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Li\u00e8ge",
                    "zip": "4000",
                    "country": "Belgium",
                    "geoPoint": {
                        "lat": 50.63373,
                        "lon": 5.56749
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Belo Horizonte",
                    "zip": "30150-221",
                    "country": "Brazil",
                    "geoPoint": {
                        "lat": -19.92083,
                        "lon": -43.93778
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Porto Alegre",
                    "zip": "90035903",
                    "country": "Brazil",
                    "geoPoint": {
                        "lat": -30.03306,
                        "lon": -51.23
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Salvador",
                    "zip": "40150-150",
                    "country": "Brazil",
                    "geoPoint": {
                        "lat": -12.97111,
                        "lon": -38.51083
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Sofia",
                    "zip": "1784",
                    "country": "Bulgaria",
                    "geoPoint": {
                        "lat": 42.69751,
                        "lon": 23.32415
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Santiago",
                    "zip": "8420383",
                    "country": "Chile",
                    "geoPoint": {
                        "lat": -33.45694,
                        "lon": -70.64827
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Baotou",
                    "zip": "14010",
                    "country": "China",
                    "geoPoint": {
                        "lat": 40.65222,
                        "lon": 109.82222
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Beijing",
                    "zip": "100029",
                    "country": "China",
                    "geoPoint": {
                        "lat": 39.9075,
                        "lon": 116.39723
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Beijing",
                    "zip": "100050",
                    "country": "China",
                    "geoPoint": {
                        "lat": 39.9075,
                        "lon": 116.39723
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Changchun",
                    "zip": "130021",
                    "country": "China",
                    "geoPoint": {
                        "lat": 43.88,
                        "lon": 125.32278
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Chengdu",
                    "zip": "610021",
                    "country": "China",
                    "geoPoint": {
                        "lat": 30.66667,
                        "lon": 104.06667
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Chongqing",
                    "zip": "400016",
                    "country": "China",
                    "geoPoint": {
                        "lat": 29.56278,
                        "lon": 106.55278
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Guangzhou",
                    "zip": "510120",
                    "country": "China",
                    "geoPoint": {
                        "lat": 23.11667,
                        "lon": 113.25
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Hangzhou",
                    "zip": "310003",
                    "country": "China",
                    "geoPoint": {
                        "lat": 30.29365,
                        "lon": 120.16142
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Heilongjiang",
                    "zip": "150086",
                    "country": "China",
                    "geoPoint": {
                        "lat": 28.3534,
                        "lon": 103.964
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Jinan",
                    "zip": "250022",
                    "country": "China",
                    "geoPoint": {
                        "lat": 36.66833,
                        "lon": 116.99722
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Kunming",
                    "zip": "650101",
                    "country": "China",
                    "geoPoint": {
                        "lat": 25.03889,
                        "lon": 102.71833
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Nanchang",
                    "zip": "330006",
                    "country": "China",
                    "geoPoint": {
                        "lat": 28.68396,
                        "lon": 115.85306
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Nanjing",
                    "zip": "210042",
                    "country": "China",
                    "geoPoint": {
                        "lat": 32.06167,
                        "lon": 118.77778
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Shanghai",
                    "zip": "200025",
                    "country": "China",
                    "geoPoint": {
                        "lat": 31.22222,
                        "lon": 121.45806
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Shanghai",
                    "zip": "200443",
                    "country": "China",
                    "geoPoint": {
                        "lat": 31.22222,
                        "lon": 121.45806
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Shenzhen",
                    "zip": "518020",
                    "country": "China",
                    "geoPoint": {
                        "lat": 22.54554,
                        "lon": 114.0683
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Shijiazhuang",
                    "zip": "050000",
                    "country": "China",
                    "geoPoint": {
                        "lat": 38.04139,
                        "lon": 114.47861
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Wuhan",
                    "zip": "430060",
                    "country": "China",
                    "geoPoint": {
                        "lat": 30.58333,
                        "lon": 114.26667
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Barranquilla",
                    "zip": "01800",
                    "country": "Colombia",
                    "geoPoint": {
                        "lat": 10.96854,
                        "lon": -74.78132
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Bogota",
                    "zip": "110221",
                    "country": "Colombia",
                    "geoPoint": {
                        "lat": 4.60971,
                        "lon": -74.08175
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Chia",
                    "zip": "250001",
                    "country": "Colombia",
                    "geoPoint": {
                        "lat": 4.85876,
                        "lon": -74.05866
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "K\u00f8benhavn",
                    "zip": "2100",
                    "country": "Denmark",
                    "geoPoint": {
                        "lat": 55.67594,
                        "lon": 12.56553
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Bois Guillaume",
                    "zip": "76031",
                    "country": "France",
                    "geoPoint": {
                        "lat": 49.4602,
                        "lon": 1.12219
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Chambray Les Tours",
                    "zip": "37170",
                    "country": "France",
                    "geoPoint": {
                        "lat": 47.33537,
                        "lon": 0.70286
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Lille Cedex",
                    "zip": "59037",
                    "country": "France",
                    "geoPoint": {
                        "lat": 50.63297,
                        "lon": 3.05858
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Lyon Cedex 03",
                    "zip": "69437",
                    "country": "France",
                    "geoPoint": {
                        "lat": 45.74848,
                        "lon": 4.84669
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Nice",
                    "zip": "06200",
                    "country": "France",
                    "geoPoint": {
                        "lat": 43.70313,
                        "lon": 7.26608
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Paris",
                    "zip": "75010",
                    "country": "France",
                    "geoPoint": {
                        "lat": 48.85341,
                        "lon": 2.3488
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Paris",
                    "zip": "75013",
                    "country": "France",
                    "geoPoint": {
                        "lat": 48.85341,
                        "lon": 2.3488
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Paris",
                    "zip": "75014",
                    "country": "France",
                    "geoPoint": {
                        "lat": 48.85341,
                        "lon": 2.3488
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Paris",
                    "zip": "75970",
                    "country": "France",
                    "geoPoint": {
                        "lat": 48.85341,
                        "lon": 2.3488
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Toulouse Cedex 9",
                    "zip": "31059",
                    "country": "France",
                    "geoPoint": {
                        "lat": 43.60426,
                        "lon": 1.44367
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Berlin",
                    "zip": "10117",
                    "country": "Germany",
                    "geoPoint": {
                        "lat": 52.52437,
                        "lon": 13.41053
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Bochum",
                    "zip": "44791",
                    "country": "Germany",
                    "geoPoint": {
                        "lat": 51.48165,
                        "lon": 7.21648
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Dresden",
                    "zip": "01307",
                    "country": "Germany",
                    "geoPoint": {
                        "lat": 51.05089,
                        "lon": 13.73832
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Hannover",
                    "zip": "30625",
                    "country": "Germany",
                    "geoPoint": {
                        "lat": 52.37052,
                        "lon": 9.73322
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Kiel",
                    "zip": "24105",
                    "country": "Germany",
                    "geoPoint": {
                        "lat": 54.32133,
                        "lon": 10.13489
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Leipzig",
                    "zip": "04103",
                    "country": "Germany",
                    "geoPoint": {
                        "lat": 51.33962,
                        "lon": 12.37129
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Mainz",
                    "zip": "55131",
                    "country": "Germany",
                    "geoPoint": {
                        "lat": 49.98419,
                        "lon": 8.2791
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Regensburg",
                    "zip": "93053",
                    "country": "Germany",
                    "geoPoint": {
                        "lat": 49.01513,
                        "lon": 12.10161
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Wuppertal",
                    "zip": "42283",
                    "country": "Germany",
                    "geoPoint": {
                        "lat": 51.27027,
                        "lon": 7.16755
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Athens",
                    "zip": "11527, GR",
                    "country": "Greece",
                    "geoPoint": {
                        "lat": 37.97945,
                        "lon": 23.71622
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Athens",
                    "zip": "12462",
                    "country": "Greece",
                    "geoPoint": {
                        "lat": 37.97945,
                        "lon": 23.71622
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Athens",
                    "zip": "16121",
                    "country": "Greece",
                    "geoPoint": {
                        "lat": 37.97945,
                        "lon": 23.71622
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Brescia",
                    "zip": "25123",
                    "country": "Italy",
                    "geoPoint": {
                        "lat": 45.53558,
                        "lon": 10.21472
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Florence",
                    "zip": "50121",
                    "country": "Italy",
                    "geoPoint": {
                        "lat": 43.77925,
                        "lon": 11.24626
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Napoli",
                    "zip": "80138",
                    "country": "Italy",
                    "geoPoint": {
                        "lat": 40.85216,
                        "lon": 14.26811
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Rome",
                    "zip": "00168",
                    "country": "Italy",
                    "geoPoint": {
                        "lat": 41.89193,
                        "lon": 12.51133
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Torrette",
                    "zip": "60126",
                    "country": "Italy"
                },
                {
                    "facility": "Research Site",
                    "city": "Fukuoka-Shi",
                    "zip": "812-8582",
                    "country": "Japan",
                    "geoPoint": {
                        "lat": 33.6,
                        "lon": 130.41667
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Seoul",
                    "zip": "03080",
                    "country": "Korea, Republic of",
                    "geoPoint": {
                        "lat": 37.566,
                        "lon": 126.9784
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Seoul",
                    "zip": "06973",
                    "country": "Korea, Republic of",
                    "geoPoint": {
                        "lat": 37.566,
                        "lon": 126.9784
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Guadalajara",
                    "zip": "44340",
                    "country": "Mexico",
                    "geoPoint": {
                        "lat": 20.66682,
                        "lon": -103.39182
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Guadalajara",
                    "zip": "44690",
                    "country": "Mexico",
                    "geoPoint": {
                        "lat": 20.66682,
                        "lon": -103.39182
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Rotterdam",
                    "zip": "3015 GD",
                    "country": "Netherlands",
                    "geoPoint": {
                        "lat": 51.9225,
                        "lon": 4.47917
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Iloilo City",
                    "zip": "5000",
                    "country": "Philippines",
                    "geoPoint": {
                        "lat": 10.69694,
                        "lon": 122.56444
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Lipa",
                    "zip": "4217",
                    "country": "Philippines"
                },
                {
                    "facility": "Research Site",
                    "city": "Manila",
                    "zip": "1000",
                    "country": "Philippines",
                    "geoPoint": {
                        "lat": 14.6042,
                        "lon": 120.9822
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Katowice",
                    "zip": "40-851",
                    "country": "Poland",
                    "geoPoint": {
                        "lat": 50.25841,
                        "lon": 19.02754
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Olsztyn",
                    "zip": "30-229",
                    "country": "Poland",
                    "geoPoint": {
                        "lat": 53.77995,
                        "lon": 20.49416
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Poznan",
                    "zip": "60-529",
                    "country": "Poland",
                    "geoPoint": {
                        "lat": 52.40692,
                        "lon": 16.92993
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Warszawa",
                    "zip": "01-157",
                    "country": "Poland",
                    "geoPoint": {
                        "lat": 52.22977,
                        "lon": 21.01178
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Warszawa",
                    "zip": "02-507",
                    "country": "Poland",
                    "geoPoint": {
                        "lat": 52.22977,
                        "lon": 21.01178
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Kragujevac",
                    "zip": "34000",
                    "country": "Serbia",
                    "geoPoint": {
                        "lat": 44.01667,
                        "lon": 20.91667
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Cape Town",
                    "zip": "7500",
                    "country": "South Africa",
                    "geoPoint": {
                        "lat": -33.92584,
                        "lon": 18.42322
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Johannesburg",
                    "zip": "2193",
                    "country": "South Africa",
                    "geoPoint": {
                        "lat": -26.20227,
                        "lon": 28.04363
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Barcelona",
                    "zip": "08025",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 41.38879,
                        "lon": 2.15899
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Barcelona",
                    "zip": "8035",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 41.38879,
                        "lon": 2.15899
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Madrid",
                    "zip": "28006",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 40.4165,
                        "lon": -3.70256
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Madrid",
                    "zip": "28034",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 40.4165,
                        "lon": -3.70256
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Madrid",
                    "zip": "28041",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 40.4165,
                        "lon": -3.70256
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Kaohsiung",
                    "zip": "83301",
                    "country": "Taiwan",
                    "geoPoint": {
                        "lat": 22.61626,
                        "lon": 120.31333
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Taichung",
                    "zip": "404",
                    "country": "Taiwan",
                    "geoPoint": {
                        "lat": 24.1469,
                        "lon": 120.6839
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Cambridge",
                    "zip": "CB2 0QQ",
                    "country": "United Kingdom",
                    "geoPoint": {
                        "lat": 52.2,
                        "lon": 0.11667
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "Leeds",
                    "zip": "LS2 9JT",
                    "country": "United Kingdom",
                    "geoPoint": {
                        "lat": 53.79648,
                        "lon": -1.54785
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "London",
                    "zip": "NW1 2PG",
                    "country": "United Kingdom",
                    "geoPoint": {
                        "lat": 51.50853,
                        "lon": -0.12574
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "London",
                    "zip": "SE1 7EH",
                    "country": "United Kingdom",
                    "geoPoint": {
                        "lat": 51.50853,
                        "lon": -0.12574
                    }
                },
                {
                    "facility": "Research Site",
                    "city": "London",
                    "zip": "SE5 9RS",
                    "country": "United Kingdom",
                    "geoPoint": {
                        "lat": 51.50853,
                        "lon": -0.12574
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "YES",
            "description": "Qualified researchers can request access to anonymized individual patient-level data from AstraZeneca group of companies sponsored clinical trials via the request portal Vivli.org. All requests will be evaluated as per the AZ disclosure commitment: https://astrazenecagrouptrials.pharmacm.com/ST/Submission/Disclosure.\n\n\"Yes\", indicates that AZ are accepting requests for IPD, but this does not mean all requests will be approved.",
            "infoTypes": [
                "STUDY_PROTOCOL",
                "SAP"
            ],
            "timeFrame": "AstraZeneca will meet or exceed data availability as per the commitments made to the EFPIA/PhRMA Data-Sharing Principles. For details of our timelines, please refer to our disclosure commitment at https://astrazenecagrouptrials.pharmacm.com/ST/Submission/Disclosure.",
            "accessCriteria": "When a request has been approved AstraZeneca will provide access to the anonymized individual patient-level data via secure research environment Vivli.org. A Signed Data Usage Agreement (non-negotiable contract for data accessors) must be in place before accessing requested information.",
            "url": "https://vivli.org/"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000008180",
                    "term": "Lupus Erythematosus, Systemic"
                },
                {
                    "id": "D000008178",
                    "term": "Lupus Erythematosus, Cutaneous"
                }
            ],
            "ancestors": [
                {
                    "id": "D000003240",
                    "term": "Connective Tissue Diseases"
                },
                {
                    "id": "D000001327",
                    "term": "Autoimmune Diseases"
                },
                {
                    "id": "D000007154",
                    "term": "Immune System Diseases"
                },
                {
                    "id": "D000012871",
                    "term": "Skin Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M11175",
                    "name": "Lupus Erythematosus, Cutaneous",
                    "asFound": "Cutaneous Lupus Erythematosus",
                    "relevance": "HIGH"
                },
                {
                    "id": "M11177",
                    "name": "Lupus Erythematosus, Systemic",
                    "asFound": "Lupus Erythematosus",
                    "relevance": "HIGH"
                },
                {
                    "id": "M6464",
                    "name": "Connective Tissue Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M4629",
                    "name": "Autoimmune Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M10200",
                    "name": "Immune System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M15674",
                    "name": "Skin Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T1303",
                    "name": "Chronic Graft Versus Host Disease",
                    "relevance": "LOW"
                },
                {
                    "id": "T1683",
                    "name": "Cutaneous Lupus Erythematosus",
                    "asFound": "Cutaneous Lupus Erythematosus",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC17",
                    "name": "Skin and Connective Tissue Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC20",
                    "name": "Immune System Diseases"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000000911",
                    "term": "Antibodies, Monoclonal"
                }
            ],
            "ancestors": [
                {
                    "id": "D000007155",
                    "term": "Immunologic Factors"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M21860",
                    "name": "Pharmaceutical Solutions",
                    "relevance": "LOW"
                },
                {
                    "id": "M4280",
                    "name": "Antimalarials",
                    "relevance": "LOW"
                },
                {
                    "id": "M4225",
                    "name": "Antibodies",
                    "relevance": "LOW"
                },
                {
                    "id": "M10184",
                    "name": "Immunoglobulins",
                    "relevance": "LOW"
                },
                {
                    "id": "M4230",
                    "name": "Antibodies, Monoclonal",
                    "asFound": "Light source",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10201",
                    "name": "Immunologic Factors",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "PhSol",
                    "name": "Pharmaceutical Solutions"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "Infe",
                    "name": "Anti-Infective Agents"
                }
            ]
        }
    },
    "hasResults": false
}